Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy

BACKGROUND: Combination therapy using more than one drug can result in a synergetic effect in clinical treatment of cancer. For this, it is important to develop an efficient drug delivery system that can contain multiple drugs and provide high accumulation in tumor tissue. In particular, simultaneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Yeeun, Lee, Donghyun, Park, Eunyoung, Jang, Seok-young, Cheon, Seo Young, Han, Seongryeong, Koo, Heebeom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650405/
https://www.ncbi.nlm.nih.gov/pubmed/34876140
http://dx.doi.org/10.1186/s12951-021-01160-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650405/
https://www.ncbi.nlm.nih.gov/pubmed/34876140
http://dx.doi.org/10.1186/s12951-021-01160-4

Ejemplares similares